Role of Lipid-Lowering Therapy in Peripheral Artery Disease
Open Access
- 19 August 2022
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (16) , 4872
Abstract
Atherosclerosis is a multifactorial, lipoprotein-driven condition that leads to plaque formation within the arterial tree, leading to subsequent arterial stenosis and thrombosis that accounts for a large burden of cardiovascular morbidity and mortality globally. Atherosclerosis of the lower extremities is called peripheral artery disease and is a major cause of loss in mobility, amputation, and critical limb ischemia. Peripheral artery disease is a common condition with a gamut of clinical manifestations that affects an estimated 10 million people in the United States of America and 200 million people worldwide. The role of apolipoprotein B-containing lipoproteins, such as LDL and remnant lipoproteins in the development and progression of atherosclerosis, is well-established. The focus of this paper is to review existing data on lipid-lowering therapies in lower extremity atherosclerotic peripheral artery disease.Keywords
This publication has 81 references indexed in Scilit:
- An evidence-based score to detect prevalent peripheral artery disease (PAD)Vascular Medicine, 2012
- The effect of ezetimibe on peripheral arterial atherosclerosis depends upon statin use at baselineAtherosclerosis, 2011
- To screen or not to screen for peripheral arterial disease in subjects aged 80 and over in primary health care: a cross-sectional analysis from the BELFRAIL studyBMC Family Practice, 2011
- Severe hypercholesterolaemia: therapeutic goals and eligibility criteria for LDL apheresis in EuropeCurrent Opinion in Lipidology, 2010
- Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein(a) levels and prevent major adverse coronary eventsNature Reviews Cardiology, 2009
- Plasma PCSK9 levels are significantly modified by statins and fibrates in humansLipids in Health and Disease, 2008
- Genetic Susceptibility to Peripheral Arterial Disease: A Dark Corner in Vascular BiologyArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Increased Serum Lipoprotein(a) Concentrations and Low Molecular Weight Phenotypes of Apolipoprotein(a) Are Associated with Symptomatic Peripheral Arterial DiseaseClinical Chemistry, 2007
- Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditionsJournal of Vascular Surgery, 2007
- The effect of probucol on femoral atherosclerosis: The Probucol Quantitative Regression Swedish Trial (PQRST)The American Journal of Cardiology, 1994